BDTX- Black Diamond Therapeutics, Inc.

Name: Black Diamond Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Black Diamond Therapeutics, Inc. (BDTX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. BDTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Behbahani Ali	93.6K	$264.3K	-
Dir	Raman Prakash	37.1K	$104.9K	-
Dir	Dhingra Kapil	30.6K	$86.3K	-
Dir	Campbell Shannon	30.6K	$86.3K	-
Dir	Kulkarni Samarth	30.6K	$86.3K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Dec 8, 2020	Leggett Thomas	Chief Financial Officer	Sale+OE	3,000	$33.78	$101,326.80	-60.7%
Dec 3, 2020	Roberts Christopher D.	Chief Scientific Officer	Sale+OE	2,500	$32.42	$81,055.25	-100%
Dec 1, 2020	Epstein David M.	See Remarks	Sale+OE	12,000	$32.71	$392,573.74	-0.8%
Nov 30, 2020	Bolzon Bradley J Phd75	Director, 10% Owner	Sell	10,393	$33.15	$344,512.74	-0.6%
Nov 30, 2020	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	10,393	$33.15	$344,512.74	-0.6%
Nov 19, 2020	Bolzon Bradley J Phd75	Director, 10% Owner	Sell	130,017	$33.01	$4,291,861.17	-2.2%
Nov 19, 2020	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	130,017	$33.01	$4,291,861.17	-2.2%
Nov 18, 2020	Bolzon Bradley J Phd75	Director, 10% Owner	Sell	4,730	$33.05	$156,349.14	-
Nov 18, 2020	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	4,730	$33.05	$156,349.14	-
Nov 16, 2020	Bolzon Bradley J Phd75	Director, 10% Owner	Sell	4,700	$33.74	$158,586.75	-

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC